Evonik Operations GmbH has been granted European Patent EP4256341A1 for a synthetic mixed culture designed to resemble a skin microbiome. The patent covers compositions and methods related to C12N 1/20 (microorganisms) and A61K 35/00 (medicinal preparations), with applications potentially in cosmetic, pharmaceutical, and therapeutic fields. The designated states include all EU member states plus Switzerland, Norway, Turkey, and other European countries.

Patent holders and potential licensees should review the patent claims to understand the scope of protection and assess freedom-to-operate for competing products. Companies developing microbiome-based skin care, topical pharmaceutical, or probiotic products targeting skin health should evaluate whether their products fall within the patent's scope. No immediate compliance deadlines apply to this publication notice.